These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 36185183

  • 1. Predictors of early death and clinical features in newly diagnosed patients with low-intermediate risk acute promyelocytic leukemia.
    Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X.
    Front Oncol; 2022; 12():895777. PubMed ID: 36185183
    [Abstract] [Full Text] [Related]

  • 2. Effects of peripheral blood leukocyte count and tumor necrosis factor-alpha on early death in acute promyelocytic leukemia.
    Wen J, Xu F, Zhou Q, Shi L, Liu Y, Yue J, Zhang Y, Liang X.
    BMC Cancer; 2023 Jan 07; 23(1):27. PubMed ID: 36611025
    [Abstract] [Full Text] [Related]

  • 3. [Effect of triple-induction regimen including all-trans retinoic acid, arsenic trioxide plus anthracyclines for adults with non-high-risk acute promyelocytic leukemia].
    Ma RJ, Yuan XL, Jiang L, Yang SW, Yang J, Wang Z, Zhang P, Zhang L, Shang BJ, Cheng LN, Zhang Y, Zhu ZM.
    Zhonghua Yi Xue Za Zhi; 2021 Aug 10; 101(30):2387-2391. PubMed ID: 34404132
    [Abstract] [Full Text] [Related]

  • 4. [Comparison of Curative Effect between Fu Fang Huang Dai Pian and Arsenic Trioxide in Treatment of 45 Patients with Acute Promyelocytic Leukaemia].
    Wang J, Huang JB, Liu ZL, Zhang BH, Xu HG, Xue HM, Chen C.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2017 Dec 10; 25(6):1605-1610. PubMed ID: 29262883
    [Abstract] [Full Text] [Related]

  • 5. [Analysis of empirical treatment for newly diagnosed acute promyelocytic leukemia combined with disseminated intravascular coagulation].
    Yang H, Zhu CY, Wang QS, Niu JH, Zhang Q, Zhu HY, Yao ZL, Xu YY, Jing Y, Yu L.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Apr 10; 22(2):315-22. PubMed ID: 24762998
    [Abstract] [Full Text] [Related]

  • 6. Gene mutations in acute promyelocytic leukemia early death in patients treated with arsenic trioxide alone.
    Chen X, Fan S, Zhao Y, Zhou J.
    Clin Transl Oncol; 2021 Oct 10; 23(10):2171-2180. PubMed ID: 33942222
    [Abstract] [Full Text] [Related]

  • 7. [Effect of all-trans retinoic acid on the newly diagnosed acute promyelocytic leukaemia: our experience].
    Rolovitsh Z, Cholovitsh M, Elezovitsh I, Vidovitsh A, Radoshevitsh-Radojkovitsh N, Boshkovitsh D, Novak A, Basara N.
    Srp Arh Celok Lek; 1995 Oct 10; 123(11-12):279-85. PubMed ID: 16296239
    [Abstract] [Full Text] [Related]

  • 8. Clinical characteristics and analysis of related factors associated with early death in newly diagnosed patients with acute promyelocytic leukemia.
    Wang A, Zhang Z, Zhu T, Liu X, Duan Q.
    Discov Oncol; 2024 Aug 27; 15(1):375. PubMed ID: 39192064
    [Abstract] [Full Text] [Related]

  • 9. Arsenic trioxide at conventional dosage does not aggravate hemorrhage in the first-line treatment of adult acute promyelocytic leukemia.
    Cui W, Wang J, Nie RM, Zhao LL, Gao MQ, Zhu HM, Chen L, Hu J, Li JM, Shen ZX, Wang ZY, Chen SJ, Chen Z, Wang KK, Xi XD, Mi JQ.
    Eur J Haematol; 2018 Apr 27; 100(4):344-350. PubMed ID: 29266395
    [Abstract] [Full Text] [Related]

  • 10. [Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].
    Xu SN, Chen JP, Liu JP, Xia Y.
    Zhong Xi Yi Jie He Xue Bao; 2009 Nov 27; 7(11):1024-34. PubMed ID: 19912733
    [Abstract] [Full Text] [Related]

  • 11. Comparison of induction therapy in non-high risk acute promyelocytic leukemia with arsenic trioxide or in combination with ATRA.
    Ghavamzadeh A, Jalili M, Rostami S, Yaghmaie M, Aliabadi LS, Mousavi SA, Vaezi M, Fumani HK, Jahani M, Alimoghaddam K.
    Leuk Res; 2018 Mar 27; 66():85-88. PubMed ID: 29407588
    [Abstract] [Full Text] [Related]

  • 12. [Correlation Analysis between Serum Fibronectin 3 Levels and Early Severe Bleeding in Patients with Newly Diagnosed Acute Promyelocytic Leukemia].
    Zhao HB, Qiao JJ, He XH.
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2024 Aug 27; 32(4):1058-1062. PubMed ID: 39192398
    [Abstract] [Full Text] [Related]

  • 13. Influence of cytokines on early death and coagulopathy in newly diagnosed patients with acute promyelocytic leukemia.
    Zhao S, Ge Y, Li Z, Yang T.
    Front Immunol; 2023 Aug 27; 14():1100151. PubMed ID: 37063881
    [Abstract] [Full Text] [Related]

  • 14. Role of cytarabine in paediatric acute promyelocytic leukemia treated with the combination of all-trans retinoic acid and arsenic trioxide: a randomized controlled trial.
    Zhang L, Zou Y, Chen Y, Guo Y, Yang W, Chen X, Wang S, Liu X, Ruan M, Zhang J, Liu T, Liu F, Qi B, An W, Ren Y, Chang L, Zhu X.
    BMC Cancer; 2018 Apr 03; 18(1):374. PubMed ID: 29615003
    [Abstract] [Full Text] [Related]

  • 15. Improved Outcomes of All-trans-retinoic Acid and Arsenic Trioxide Plus Idarubicin as a Frontline Treatment in Adult Patients With Acute Promyelocytic Leukemia.
    Yang S, Ma R, Yuan X, Jiang L, Shi J, Yang J, Lei P, Zang Y, Chen X, Zhang Y, Liu Z, Guo J, Zhang L, Zhu X, Zhu Z.
    Clin Lymphoma Myeloma Leuk; 2020 Jul 03; 20(7):e382-e391. PubMed ID: 32336675
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Treatment of acute promyelocytic leukaemia with all-trans retinoic acid and arsenic trioxide: a paradigm of synergistic molecular targeting therapy.
    Zhou GB, Zhang J, Wang ZY, Chen SJ, Chen Z.
    Philos Trans R Soc Lond B Biol Sci; 2007 Jun 29; 362(1482):959-71. PubMed ID: 17317642
    [Abstract] [Full Text] [Related]

  • 18. ABO identical and washed blood transfusions as candidate strategies to reduce early mortality in acute promyelocytic leukemia.
    Sahai T, Henrichs K, Refaai M, Heal JM, Kirkley SA, Schmidt AE, Mendler JH, Masel D, Liesveld J, Aquina C, Blumberg N.
    Leuk Res; 2017 Nov 29; 62():1-3. PubMed ID: 28963906
    [Abstract] [Full Text] [Related]

  • 19. Walking a Tightrope: Dosage Modifications and Treatment Outcomes of All-Trans-Retinoic Acid, Arsenic Trioxide, and Daunorubicin for High-Risk Acute Promyelocytic Leukemia.
    Danthala M, Golamari KR, Seshachalam A, Mikkilineni A, Chappidi S, Mekala MB, Elangovan V, Chinnakali P.
    JCO Glob Oncol; 2020 Nov 29; 6():1749-1756. PubMed ID: 33201743
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.